Semaglutide also reduces appetite and slows digestion, leading to a decrease in food intake and weight loss
Patients in Stamford, Greenwich, Fairfield County, and throughout Connecticut can call 203-348-8805 to discuss physician-supervised GLP-1 weight loss options
When weight loss reduces exposure to these experiences and challenges internalized beliefs, self-esteem often rises dramatically
Long-term timing considerations As you settle into a GLP-1 protocol over months, your side effect profile typically improves significantly
Researchers studied 338 adults with obesity or overweight who did not have diabetes
The approval came after clinical trials involving 3,477 patients (2,519 on Zepbound and 958 on a placebo): Patients taking 5mg of Zepbound lost 15% of their body weight (study 1) Patients taking 10mg of Zepbound lost 19.5% (study 1) and 12.8% (study 2) of their body weight Patients taking 15mg of Zepbound lost 20.9% (study 1) and 14.7% (study 2) of their body weight Patients taking the placebo lost 3.1% (study 1) and 3.2% (study 2) of their body weight Zepbound was released to market on December 5, 2023, with six available dosages available to those with a prescription: 2.5mg, 5mg, 7.5mg, 10mg, 12.5mg, and 15mg